Skip to main content

Table 1 Clinical and metabolic parameters of study participants

From: Prevalence of undiagnosed type 2 diabetes in patients admitted with acute coronary syndrome: the utility of easily reproducible screening methods

Variables

Mean

S.D

Median

IQR

Min

Max

Age (Years) (n = 118)

61

11.9

61

53-71

31

90

BMI (kg/m²) (n = 106)

28

5.1

28

25-32

17

47

Baseline FPG (mmol/L) (n = 118)

5.7

1.2

5.4

5.0-6.0

4.3

13.1

Baseline 2 hr PG (mmol/L) (n = 118)

8.5

3.7

7.7

5.9-9.9

2.4

23.5

Baseline HbA1c (%)a mmol/mol (n = 117)

6.1 (43)

0.84

5.9

5.7-6.2

4.8 (29)

10.6 (92)

Follow up FPG (n = 92)b

5.7

0.99

5.6

5.2 – 6.1

2.1

10.4

Follow up 2 hr PG (n = 91)b

6.8

2.8

5.9

5-8.5

2.4

15.4

Follow up HbA1c (n = 96)

6.2

0.8

5.9

5.7-6.3

5.1

10.8

Systolic BP (mmHg) (n = 110)

126

20.5

122

110-138

91

192

Diastolic BP (mmHg) (n = 110)

74

12

73

65-81

47

115

Fructosamine (μmol/L) (n = 86)

213

28.7

210

196-228.2

169

401

  1. The total study population was 118, 8 patients has missing data for BP and 12 patients has missing data for BMI
  2. aHbA1c was not reported in one participant due to the presence of variant Haemoglobin
  3. bFor the follow up OGTT we had data for 92 patients. Out of 118 who had baseline data, 14 were lost to follow up, 3 deceased, 8 did not have follow up OGTT because they were initiated on treatment for T2DM, and 1 did not have follow up OGTT due to HbA1c variant